An evaluation of Ibrutinib for the treatment of Waldenstrom macroglobulinaemia
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1770727
Abstract: ABSTRACT Introduction Waldenstrom Macroglobulinaemia (WM) is a heterogenous condition which poses a challenge to manage. Novel therapies such as Ibrutinib have been shown to be efficacious in treating WM. The landscape of Ibrutinib’s role in… read more here.
Keywords: ibrutinib; ibrutinib treatment; waldenstrom macroglobulinaemia; evaluation ibrutinib ... See more keywords
Evaluation of Ibrutinib Cardiotoxicity By Comparative Use of Speckle-Tracking Technique and Biomarkers
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001463
Abstract: Background: Ibrutinib, a relatively new antineoplastic agent, has multiple cardiovascular effects that are still insufficiently known and evaluated, including subclinical myocardial damage. Study Question: The present study aims to assess the role of the myocardial… read more here.
Keywords: increase; myocardial strain; ibrutinib cardiotoxicity; cardiotoxicity ... See more keywords